Agenda – Thursday 4 September Workshop chairpersons: Mitsumasa Kishimoto and Katy Leung 10:45～12:45 歓迎の挨拶と導入 キシモト・ミツマサ GRAPPAの最近の活動報告 ケイティ・リョン 管理困難な乾癬性関節炎（PsA）／治療選択 アーサー・カバナー パネルディスカッション 体軸型乾癬性関節炎とは何か？ ピーター・ナッシュ AXIS研究の最新情報 ライシャン・タム Q&A
Synopsis: Empowering patients through education is a transformative approach in rheumatology. It enables individuals to understand and manage their conditions better while improving clinical outcomes.
Synopsis: This session reviews and highlights recent developments in the pathogenesis and management of antiphospholipid syndrome and lupus nephritis. LEARNING OBJECTIVES: Provide an overview on
Synopsis: Interstitial lung disease (ILD) is characterized by inflammation and/or fibrosis of the lung parenchyma and is a leading cause of morbidity and mortality in
Synopsis: Interventional rheumatology is a burgeoning field involving minimally invasive diagnostic and therapeutic procedures in patients with rheumatic and musculoskeletal diseases, these procedures include ultrasound-guided
Synopsis: Information coming soon. Agenda – Thursday 4 September Workshop chairpersons: TBA 0800-1030 Systemic Sclerosis Masataka Kuwana Idiopathic Inflammatory Myositis Speaker TBA Chest imaging and
Synopsis: In this workshop, the participants will gain an understanding of large-vessel vasculitis including the real-world data, the new disease concept of GCA-PMR spectrum, and
Synopsis: IL-6 plays a central role in the inflammatory process of several rheumatic diseases. IL-6 inhibitors have significantly impacted the treatment of these diseases, particularly
Synopsis: We invite you to the upcoming GRAPPA Workshop on AXIS study and MRI advancements. This workshop is an excellent opportunity for professionals to further
The workshop agenda and associated costs will be provided in due course. Time3 Sep 0800-19004 Sep 0800-1630 CostMSUS – Full delegate 2 day – $650.00MSUS
From key date reminders, abstract closures, program release updates, and speaker announcements, the best place to stay across APLAR Congress information is with the official congress mailing list.
You can opt out at anytime.
If you are translating this website, phrase based translation is used and may not be completely accurate.
